Literature DB >> 9696818

Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

B D Zelus1, D R Wessner, R K Williams, M N Pensiero, F T Phibbs, M deSouza, G S Dveksler, K V Holmes.   

Abstract

Mouse hepatitis virus receptor (MHVR) is a murine biliary glycoprotein (Bgp1(a)). Purified, soluble MHVR expressed from a recombinant vaccinia virus neutralized the infectivity of the A59 strain of mouse hepatitis virus (MHV-A59) in a concentration-dependent manner. Several anchored murine Bgps in addition to MHVR can also function as MHV-A59 receptors when expressed at high levels in nonmurine cells. To investigate the interactions of these alternative MHVR glycoproteins with MHV, we expressed and purified to apparent homogeneity the extracellular domains of several murine Bgps as soluble, six-histidine-tagged glycoproteins, using a baculovirus expression system. These include MHVR isoforms containing four or two extracellular domains and the corresponding Bgp1(b) glycoproteins from MHV-resistant SJL/J mice, as well as Bgp2 and truncation mutants of MHVR and Bgp1(b) comprised of the first two immunoglobulin-like domains. The soluble four-domain MHVR glycoprotein (sMHVR[1-4]) had fourfold more MHV-A59 neutralizing activity than the corresponding soluble Bgp1(b) (sBgp1(b)) glycoprotein and at least 1,000-fold more neutralizing activity than sBgp2. Although virus binds to the N-terminal domain (domain 1), soluble truncation mutants of MHVR and Bgp1(b) containing only domains 1 and 2 bound virus poorly and had 10- and 300-fold less MHV-A59 neutralizing activity than the corresponding four-domain glycoproteins. In contrast, the soluble MHVR glycoprotein containing domains 1 and 4 (sMHVR[1,4]) had as much neutralizing activity as the four-domain glycoprotein, sMHVR[1-4]. Thus, the virus neutralizing activity of MHVR domain 1 appears to be enhanced by domain 4. The sBgp1(b)[1-4] glycoprotein had 500-fold less neutralizing activity for MHV-JHM than for MHV-A59. Thus, MHV strains with differences in S-glycoprotein sequence, tissue tropism, and virulence can differ in the ability to utilize the various murine Bgps as receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696818      PMCID: PMC109946     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

Review 1.  Virus receptors: implications for pathogenesis and the design of antiviral agents.

Authors:  L C Norkin
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus.

Authors:  C Godfraind; S G Langreth; C B Cardellichio; R Knobler; J P Coutelier; M Dubois-Dalcq; K V Holmes
Journal:  Lab Invest       Date:  1995-11       Impact factor: 5.662

3.  Overexpression of the MHV receptor. Effect on progeny virus secretion.

Authors:  T M Gallagher
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

4.  Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells.

Authors:  D L Jarvis; E E Finn
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

5.  Structure and function of C-CAM1: effects of the cytoplasmic domain on cell aggregation.

Authors:  S H Lin; W Luo; K Earley; P Cheung; D C Hixson
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

6.  The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity.

Authors:  M Gromeier; H H Lu; G Bernhardt; J J Harber; J A Bibb; E Wimmer
Journal:  Ann N Y Acad Sci       Date:  1995-05-25       Impact factor: 5.691

7.  Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain.

Authors:  G S Dveksler; A A Basile; C B Cardellichio; K V Holmes
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus.

Authors:  D S Chen; M Asanaka; K Yokomori; F Wang; S B Hwang; H P Li; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  The cea10 gene encodes a secreted member of the murine carcinoembryonic antigen family and is expressed in the placenta, gastrointestinal tract and bone marrow.

Authors:  U Keck; P Nédellec; N Beauchemin; J Thompson; W Zimmermann
Journal:  Eur J Biochem       Date:  1995-04-15

10.  Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.

Authors:  E Colston; V R Racaniello
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  26 in total

1.  Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm-egg fusion.

Authors:  Diego A Ellerman; Cam Ha; Paul Primakoff; Diana G Myles; Gabriela S Dveksler
Journal:  Mol Biol Cell       Date:  2003-10-03       Impact factor: 4.138

2.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Expression of the mouse hepatitis virus receptor by central nervous system microglia.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Kathryn V Holmes; Stephen A Stohlman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter.

Authors:  M H Verheije; T Würdinger; V W van Beusechem; C A M de Haan; W R Gerritsen; P J M Rottier
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

Authors:  D E Wentworth; K V Holmes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein.

Authors:  Evelena Ontiveros; Taeg S Kim; Thomas M Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59.

Authors:  Erin Hemmila; Claire Turbide; Melanie Olson; Serge Jothy; Kathryn V Holmes; Nicole Beauchemin
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  CEACAM1 recognition by bacterial pathogens is species-specific.

Authors:  Maike Voges; Verena Bachmann; Robert Kammerer; Uri Gophna; Christof R Hauck
Journal:  BMC Microbiol       Date:  2010-04-20       Impact factor: 3.605

9.  Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.

Authors:  S Navas; S H Seo; M M Chua; J Das Sarma; E Lavi; S T Hingley; S R Weiss
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Authors:  Hideka S Miura; Keiko Nakagaki; Fumihiro Taguchi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.